Additionally, FDA is proposing two other constraints around the submission of a supplemental PMTA. Below proposed §?1114.fifteen(a), a supplemental PMTA could not be submitted the place the marketing purchase for the original tobacco solution is withdrawn or continues to be briefly suspended or is the subject of momentary suspension or withdrawal